A Bayesian adaptive design for addressing correlated late-onset outcomes in phase I/II randomized trials of drug combinations in oncology (Q5866135)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: A Bayesian adaptive design for addressing correlated late-onset outcomes in phase I/II randomized trials of drug combinations in oncology |
scientific article; zbMATH DE number 7540820
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Bayesian adaptive design for addressing correlated late-onset outcomes in phase I/II randomized trials of drug combinations in oncology |
scientific article; zbMATH DE number 7540820 |
Statements
A Bayesian adaptive design for addressing correlated late-onset outcomes in phase I/II randomized trials of drug combinations in oncology (English)
0 references
13 June 2022
0 references
adaptive design
0 references
drug combination
0 references
late-onset outcomes
0 references
phase I/II randomized trial
0 references
